Genetic deletion of trkB.T1 increases neuromuscular function

Area of Science:

• Neuroscience
• Molecular Biology
• Physiology

Background:

• The full-length tropomyosin receptor kinase B (trkB.FL) is crucial for neuromuscular synapse maintenance.
• The role of the alternative splice variant, truncated trkB (trkB.T1), in the peripheral neuromuscular system is largely unknown.

Purpose of the Study:

• To investigate the function of trkB.T1 in the peripheral neuromuscular axis.
• To determine the impact of trkB.T1 absence on neuromuscular performance and muscle function.

Main Methods:

• Utilized trkB.T1 null mice for in vivo and in vitro studies.
• Assessed in vivo neuromuscular performance and nerve-evoked muscle tension.
• Performed in vitro assays to evaluate muscle contractility and calcium release.
• Analyzed Akt activation in resting and active muscle tissue.

Main Results:

• trkB.T1 null mice exhibited significantly enhanced in vivo neuromuscular performance and nerve-evoked muscle tension.
• In vitro studies revealed increased muscle contractility and electrically evoked calcium release in trkB.T1 null mice.
• Absence of trkB.T1 led to increased Akt activation in resting muscle and enhanced trkB.FL and Akt activation during contractile activity.

Conclusions:

• The truncated trkB.T1 receptor variant acts as a negative modulator of neuromuscular function.
• The trkB signaling pathway, particularly in relation to trkB.FL and Akt activation, presents a potential therapeutic target for neuromuscular deficits.